Sempresto, Inc., a medical device company focused on transforming access to emergency medications, today announced that its ...
Healthcare providers, parents and caregivers have two new reviews to look to for a clearer understanding on barriers to ...
UK drivers are being warned to clear one everyday thing from the car before Wednesday, as the heat turns a parked cabin into a quiet threat.
ARS Pharma has experienced a >65% decline since my previous 'Hold' rating, reflecting significant commercialization challenges. Click for more on SPRY stock.
2UrbanGirls on MSN
Allergy shots at home? A 23,614-patient study is getting a second look
For millions of Americans with seasonal or year-round allergies, allergy shots are one form of allergy immunotherapy (AI ...
healthdigest.com on MSN
Avoid taking ibuprofen if you have this allergy
It makes sense if you have a drug allergy to switch to another one that does the same thing. If you're allergic to this, though, you'll want to avoid ibuprofen.
Orexo CEO Nikolaj Sørensen is making a bold bet: that a dry powder puffed into the nose can replace injections, daily tablets ...
Autoinjector concept, developed in collaboration with Sagentia Medical, aims to help ensure life-saving epinephrine is always within reach. Sempresto, Inc., a medical device company focused on transfo ...
All the Latest Game Footage and Images from Adrenaline Injection Adrenaline Injection is the Demo version of Adrenaline Rampage game – Survivor platformer. You are trapped in a distorted space city.
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced the market launch of neffy® 2 mg in Canada following the approval by Health Canada in April 2026. The launch of this first ever nasal ...
U.S. neffy ® net product revenue in Q2 2026; total U.S. epinephrine market share for Type 1 allergies of 5% and 8% share within ...
Australia has a reputation for harboring some particularly heinous wildlife. There are more than 100 species of venomous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results